Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Standard of Care × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Hematologic Neoplasms 5 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Mouth Neoplasms 3 Lung Neoplasms 3 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Malignant Solid Neoplasm 2 Leukemia, Myeloid, Acute 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Xerostomia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tonsillar Neoplasms 1 Tongue Neoplasms 1 Teratoma 1 Stomatitis 1 Sleep Initiation and Maintenance Disorders 1 Skin Neoplasms 1 Skin Carcinoma 1 Renal Insufficiency, Chronic 1 Radiodermatitis 1 Pyloric Stenosis, Hypertrophic 1 Prostate Cancer Metastatic 1

Interventions

Gemcitabine 20 pembrolizumab 14 Specimen Handling 14 Magnetic Resonance Spectroscopy 14 Cisplatin 13 enfortumab vedotin 7 Nivolumab 7 Carboplatin 6 Mitomycin 5 Docetaxel 5 Cystoscopy 5 Biopsy 5 avelumab 4 Transurethral Resection of Bladder 4 Radiation 4 Mitozytrex 4 Fluorouracil 4 erdafitinib 3 durvalumab 3 dehydroftorafur 3 cabozantinib 3 atezolizumab 3 Platinum 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 sapanisertib 2 sacituzumab govitecan 2 relatlimab 2 eribulin 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07524426 2026-04-13

LORUP

Umeå University

Phase NA Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡